If you are a professional fund manager looking for an investor for your fund, EIFO may be an option. We invest in funds that invest in unlisted companies within a wide range of sectors.
Long-term
We build long-term partnerships and focus on network building with venture funds across multiple life cycles.
Commercial
We engage at a strategic level, but first and foremost we are a commercial investor – with a strong focus on financial returns.
Catalytic
We prioritise nurturing new innovation in Denmark for the benefit of the local ecosystem – with an international perspective.
Comprehensive
Our investment approach is broad-based: from tech, climate, and life science to deep tech, defense, and the commercialisation of research. We can invest at a very early pre-seed stage, but also further up the market at the growth stage.
All our investments are made on a commercial basis, and the funds we invest in are managed by professional fund managers with specialised expertise in the types of companies they invest in.
We always invest as part of a syndicate with other investors, thereby helping to ensure that private capital is also attracted to the funds.
Here you can read more about the different criteria we use to assess the funds we enter into partnerships with.
The team must have the relevant experience as well as the required strategic and operational competences. The team must demonstrate good collaboration and have access to a strong network in support of the fund's investment strategy.
The investment strategy must be clearly defined and describe in detail how value is created in the enterprises all the way to exit. The investments must comply with basic social and ethical principles.
The team ranks among the best investors in their field with demonstrated returns on both previous and current investments. The team's proven results include their choice of investments, investment structuring, development of portfolio companies and exit.
Structured workflow and processes have been established which ensure consistent and efficient execution of the fund's investment strategy. The team works systematically to create value and handle risk, and there is a clear framework for assigning responsibility. The procedures include documentation and communication (including reporting).
The fund has a clear legal and tax structure which include transparent terms and conditions adhering to market conformity so that the risk/return aspect is balanced for all relevant parties.
The European life science venture fund Sofinnova Partners has just closed a new bio- and medtech investment fund totalling 650 million euro.
In 2022, the Danish Export and Investment Fund (EIFO), Velliv, and Finansforbundet, in collaboration with Copenhagen Fintech, established Upfin.
EIFO announces an investment of US$5 million into D3, a defence technology venture fund with a strong presence and track-record in Ukraine. T
